Intended for healthcare professionals
Quality of life

Atopic dermatitis – the impact on quality of life and economic burden

Stela Ziaj

MBBS BSc MRCP Specialist Registrar, Welsh Institute of Dermatology, Cardiff, UK

Andrew Y Finlay

CBE FRCP Professor of Dermatology, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK

Mahbub MU Chowdhury

FRCP FAcadMEd Consultant Dermatologist, Welsh Institute of Dermatology, Cardiff, UK

It has now become common practice in dermatology outpatient assessments to include a Patient Oriented Eczema Measure (POEM) or Eczema Area and Severity Index (EASI) score when measuring atopic dermatitis severity and The Dermatology Life Quality Index (DLQI) or The Children's Dermatology Life Quality Index (CDLQI) to assess the effect on quality of life. This article presents a review of atopic dermatitis and its major economic burden and impact on quality of life, especially in moderate to severe disease.

Dermatology in practice 2019; 25(2): 50–53
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)